ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.

RSLS ReShape Lifesciences Inc

0,1693
-0,006 (-3,42%)
Nach Börsenschluss
Zuletzt aktualisiert: 23:28:36
Verzögert um 15 Minuten
Name Symbol Markt Aktientyp
ReShape Lifesciences Inc RSLS NASDAQ Common Stock
  Änderung Änderung % Aktuell Zeit
-0,006 -3,42% 0,1693 23:28:36
Handelsbeginn Niedrig Hoch Schlusskurs Handelsende
0,175 0,1676 0,179 0,1693 0,1753
more quote information »

Aktuelle News

Datum Zeit Quelle Überschrift
01.4.202422:05GLOBEReShape Lifesciences® Reports Year Ended December 31, 2023..
28.3.202413:31GLOBEReShape Lifesciences® Receives Notice of Allowance for..
04.3.202414:31GLOBEReShape Lifesciences® Provides Update on 2024 Cost Reduction..
26.2.202422:19EDGAR2Form 8-K - Current report
22.2.202414:31GLOBEReShape Lifesciences® Announces First Surgeries Utilizing..
24.1.202414:31GLOBEReShape Lifesciences® Conducts Bariatric Fellows Training..
18.1.202422:38EDGAR2Form 8-K - Current report
17.1.202400:11EDGAR2Form 3 - Initial statement of beneficial ownership of..
05.1.202422:14EDGAR2Form PRE 14A - Other preliminary proxy statements
20.12.202314:31GLOBEReShape Lifesciences® Engages Maxim Group LLC To Identify..
12.12.202322:05GLOBEReShape Lifesciences® Receives FDA PMA Supplement Approval..
29.11.202322:05EDGAR2Form 8-K - Current report
21.11.202314:06GLOBEReShape Lifesciences® Enters into Warrant Exercise..
08.11.202322:05GLOBEReShape Lifesciences® Reports Third Quarter Ended September..
06.11.202314:31GLOBEReShape Lifesciences® to Announce Financial Results for the..
13.10.202322:42EDGAR2Form 8-K - Current report
05.10.202322:05EDGAR2Form 8-K - Current report
03.10.202315:23EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
29.9.202318:30GLOBEReShape Lifesciences® Announces Pricing of $3.0 Million..
27.9.202323:30EDGAR2Form S-1/A - General form for registration of securities..
22.9.202322:02EDGAR2Form 8-K - Current report
22.9.202314:31GLOBEReShape Lifesciences® Announces Participation in the LD..
21.9.202314:31GLOBEReShape Lifesciences® Signs Exclusive License Agreement With..
19.9.202314:31GLOBEReShape Lifesciences® Significantly Strengthens Patent..
14.9.202314:31GLOBEReShape Lifesciences® Receives NIH SBIR Grant to Further..
25.8.202322:41EDGAR2Form S-1 - General form for registration of securities under..
07.8.202323:26EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07.8.202322:54EDGAR2Form 8-K - Current report
07.8.202322:05GLOBEReShape Lifesciences® Reports Second Quarter Ended June 30,..
03.8.202322:05GLOBEReShape Lifesciences® to Announce Financial Results for the..
29.6.202314:31GLOBEReShape Lifesciences® Signs Preferred Partner Agreement With..
28.6.202314:31GLOBEReShape Lifesciences® Presents Data on its Proprietary..
26.6.202322:05GLOBEReShape Lifesciences® Submits FDA PMA Supplement Application..
23.6.202314:35GLOBELife Science Investor Forum: Presentations Now Available for..
20.6.202316:58GLOBELife Science Investor Forum Agenda Announced for June 22nd
14.6.202314:31GLOBEReShape Lifesciences® to Participate in Investor and..
15.5.202322:05GLOBEReShape Lifesciences® Reports First Quarter Ended March 31,..
11.5.202314:30GLOBEReShape Lifesciences® to Announce Financial Results for the..

Kürzlich von Ihnen besucht

Delayed Upgrade Clock